Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pall To Acquire ATMI | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pall To Acquire ATMI

Adds single-use biosystems and consumables

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Pall Corp. will acquire the ATMI LifeSciences business of ATMI, Inc. for $185 million. ATMI LifeSciences makes and sells single-use bioprocess systems and consumables for the pharma and biopharma industries. The deal is expected to close by the end of Pall’s third quarter, which ends in April 2014. For the balance of fiscal 2014, Pall expects the acquisition to add $20 to $30 million in revenue.
 
“This acquisition immediately strengthens our offering and broadens our already extensive portfolio of advanced solutions for biopharmaceutical customers,” said Larry Kingsley, Pall’s chairman and chief executive officer.
 
Doug Neugold, ATMI’s chief executive officer, said, “We are very happy to have Pall as the new owner of this business, and believe the fit and their capabilities will accelerate its growth and provide great support to our customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics